Article
Pilot study of the G-protein beta3 subunit gene (C825T) polymorphism and clinical response to olanzapine or olanzapine-related weight gain in persons with schizophrenia.
Medical science monitor : international medical journal of experimental and clinical research - 1 Feb 2006
Bishop Jeffrey R, Ellingrod Vicki L, Moline Jessica, Miller Del
Abstract excerpt
BACKGROUND: Despite advances in schizophrenia treatment, nearly 30% of patients do not respond to atypical antipsychotic agents, such as olanzapine. Furthermore, 30-60% of patients will gain significant weight during the course of olanzapine therapy. Little research has been done to investigate t...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.